Cargando…
Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969597/ https://www.ncbi.nlm.nih.gov/pubmed/33731792 http://dx.doi.org/10.1038/s41598-021-85720-6 |
_version_ | 1783666257040506880 |
---|---|
author | Al‑Darraji, Ahmed Donahue, Renée R. Tripathi, Himi Peng, Hsuan Levitan, Bryana M. Chelvarajan, Lakshman Haydar, Dalia Gao, Erhe Henson, David Gensel, John C. Feola, David J. Venditto, Vincent J. Abdel‑Latif, Ahmed |
author_facet | Al‑Darraji, Ahmed Donahue, Renée R. Tripathi, Himi Peng, Hsuan Levitan, Bryana M. Chelvarajan, Lakshman Haydar, Dalia Gao, Erhe Henson, David Gensel, John C. Feola, David J. Venditto, Vincent J. Abdel‑Latif, Ahmed |
author_sort | Al‑Darraji, Ahmed |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7969597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-79695972021-03-19 Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction Al‑Darraji, Ahmed Donahue, Renée R. Tripathi, Himi Peng, Hsuan Levitan, Bryana M. Chelvarajan, Lakshman Haydar, Dalia Gao, Erhe Henson, David Gensel, John C. Feola, David J. Venditto, Vincent J. Abdel‑Latif, Ahmed Sci Rep Author Correction Nature Publishing Group UK 2021-03-17 /pmc/articles/PMC7969597/ /pubmed/33731792 http://dx.doi.org/10.1038/s41598-021-85720-6 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Author Correction Al‑Darraji, Ahmed Donahue, Renée R. Tripathi, Himi Peng, Hsuan Levitan, Bryana M. Chelvarajan, Lakshman Haydar, Dalia Gao, Erhe Henson, David Gensel, John C. Feola, David J. Venditto, Vincent J. Abdel‑Latif, Ahmed Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction |
title | Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction |
title_full | Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction |
title_fullStr | Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction |
title_full_unstemmed | Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction |
title_short | Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction |
title_sort | author correction: liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969597/ https://www.ncbi.nlm.nih.gov/pubmed/33731792 http://dx.doi.org/10.1038/s41598-021-85720-6 |
work_keys_str_mv | AT aldarrajiahmed authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT donahuereneer authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT tripathihimi authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT penghsuan authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT levitanbryanam authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT chelvarajanlakshman authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT haydardalia authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT gaoerhe authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT hensondavid authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT genseljohnc authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT feoladavidj authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT vendittovincentj authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction AT abdellatifahmed authorcorrectionliposomaldeliveryofazithromycinenhancesitsimmunotherapeuticefficacyandreducestoxicityinmyocardialinfarction |